BSE Live
Oct 07, 16:01Prev. Close
2020.70
Open Price
2030.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 07, 15:57Prev. Close
2021.40
Open Price
2030.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1997.00 (5)
Profit & Loss account of Caplin Point Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 1,921.23 | 1,676.78 | 1,453.82 | 1,263.01 | 1,048.26 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 1,921.23 | 1,676.78 | 1,453.82 | 1,263.01 | 1,048.26 | |
Total Operating Revenues | 1,937.47 | 1,694.10 | 1,466.73 | 1,269.41 | 1,061.29 | |
Other Income | 96.43 | 66.94 | 55.98 | 38.75 | 23.54 | |
Total Revenue | 2,033.90 | 1,761.04 | 1,522.71 | 1,308.16 | 1,084.83 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 248.45 | 239.81 | 206.28 | 192.31 | 129.82 | |
Purchase Of Stock-In Trade | 483.83 | 558.92 | 503.87 | 397.12 | 259.57 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 3.36 | |
Changes In Inventories Of FGWIP And Stock In Trade | 38.56 | -74.55 | -46.94 | -31.92 | 82.35 | |
Employee Benefit Expenses | 177.72 | 143.59 | 136.99 | 115.30 | 102.53 | |
Finance Costs | 0.61 | 0.78 | 0.78 | 0.70 | 1.59 | |
Depreciation And Amortisation Expenses | 65.96 | 53.44 | 44.99 | 46.90 | 36.97 | |
Other Expenses | 341.98 | 274.89 | 225.47 | 201.93 | 155.02 | |
Total Expenses | 1,357.11 | 1,196.88 | 1,071.44 | 922.34 | 771.21 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 676.79 | 564.16 | 451.27 | 385.82 | 313.62 | |
Exceptional Items | -0.01 | 0.27 | 0.08 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 676.78 | 564.43 | 451.35 | 385.82 | 313.62 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 125.33 | 101.55 | 82.09 | 83.91 | 71.14 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 10.36 | 1.46 | -7.73 | -6.54 | -8.96 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 135.69 | 103.01 | 74.36 | 77.37 | 62.19 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 541.09 | 461.42 | 376.99 | 308.45 | 251.43 | |
Profit/Loss From Continuing Operations | 541.09 | 461.42 | 376.99 | 308.45 | 251.43 | |
Profit/Loss For The Period | 541.09 | 461.42 | 376.99 | 308.45 | 251.43 | |
Minority Interest | -4.78 | -4.33 | -0.73 | -8.61 | -9.16 | |
Consolidated Profit/Loss After MI And Associates | 536.31 | 457.09 | 376.26 | 299.84 | 242.27 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 71.00 | 60.00 | 50.00 | 40.00 | 32.00 | |
Diluted EPS (Rs.) | 70.00 | 60.00 | 49.00 | 39.00 | 32.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 34.17 | 30.32 | 0.00 | 3.03 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
28.08.2025
21.08.2025
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
17.06.2025
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
15.05.2025
Caplin Labs Consolidated March 2025 Net Sales at Rs 502.45 crore, up 10.86% Y-o-Y
15.05.2025
Caplin Labs Standalone March 2025 Net Sales at Rs 173.61 crore, up 24.56% Y-o-Y
07.02.2025
Caplin Labs Consolidated December 2024 Net Sales at Rs 492.96 crore, up 13.19% Y-o-Y